Launch event – 25 May 2024 at Living Tomorrow
Novartis organizes a new event on Saturday 25th of May to launch the reimbursement of our latest treatment for Metastatic castration-resistant Prostate Cancer (mCRPC) for health care professionals involved in the treatment of these patients. This event will have a mixed of international and national experts discussing the latest development in precision medicine as well as challenging patient cases.
If you are involved in treating prostate cancer, please click here to register to this exciting event.
BE2404104679
